Amir Momeni-Boroujeni

Amir Momeni-Boroujeni


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2024 in Gynecologic Oncology
Verified
Journal Article
Closed access
SMSara Moufarrij
Sara Moufarrij
AGAndrea Gazzo
Andrea Gazzo
SRSatshil Rana
Satshil Rana
PSPier Selenica
Pier Selenica
NANadeem R. Abu-Rustum
Nadeem R. Abu-Rustum
AMAmir Momeni-Boroujeni
Amir Momeni-Boroujeni

24 May 2025 in Gynecologic Oncology
Verified
Journal Article
Closed access
CLClarissa Lam
Clarissa Lam
QZQin Zhou
Qin Zhou
CACarol Aghajanian
Carol Aghajanian
NANadeem R. Abu-Rustum
Nadeem R. Abu-Rustum
JMJennifer J. Mueller
Jennifer J. Mueller
AMAmir Momeni-Boroujeni
Amir Momeni-Boroujeni

6 November 2024 in Gynecologic Oncology
Verified
Journal Article
Closed access
SMSara Moufarrij
Sara Moufarrij
YLYulia Lakhman
Yulia Lakhman
CACarol Aghajanian
Carol Aghajanian
NANadeem Abu-Rustum
Nadeem Abu-Rustum
LELora H. Ellenson
Lora H. Ellenson
AMAmir Momeni-Boroujeni
Amir Momeni-Boroujeni

8 December 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
RMRachelle P Mendoza
Rachelle P Mendoza
AMAmir Momeni-Boroujeni
Amir Momeni-Boroujeni
NSNayanendu Saha
Nayanendu Saha
JAJuwairiya Arshi
Juwairiya Arshi
EGElmer C. Gabutan
Elmer C. Gabutan
DNDimitar B. Nikolov
Dimitar B. Nikolov
The viral agent SARS-CoV-2 clearly affects several organ systems, including the cardiovascular system. Angiopoietins are involved in vascular integrity and angiogenesis. Angiopoietin-1 (Ang1) promotes vessel stabilization, while angiopoietin-2 (Ang2), which is usually expressed at low levels, is significantly elevated in inflammatory and angiogenic conditions. Interleukin-6 (IL-6) is known to induce defective angiogenesis via the activation of the Ang2 pathway. Vasculitis and vasculopathy are some of the defining features of moderate to severe COVID-19-associated systemic disease. We investigated the serum levels of angiopoietins, as well as interleukin-6 levels and anti-SARS-CoV2 IgG titers, in hospitalized COVID-19 patients across disease severity and healthy controls. Ang2 levels were elevated in COVID-19 patients across all severity compared to healthy controls, while Ang1 levels were decreased. The patients with adverse outcomes (death and/or prolonged hospitalization) had relatively lower and stable Ang1 levels but continuously elevated Ang2 levels, while those who had no adverse outcomes had increasing levels of both Ang1 and Ang2, followed by a decrease in both. These results suggest that the dynamic levels of Ang1 and Ang2 during the clinical course may predict adverse outcomes in COVID-19 patients. Ang1 seems to play an important role in controlling Ang2-related inflammatory mechanisms in COVID-19 patients. IL-6 and anti-SARS-CoV2 spike protein IgG levels were significantly elevated in patients with severe disease. Our findings represent an informative pilot assessment into the role of the angiopoietin signaling pathway in the inflammatory response in COVID-19.

11 March 2026 in Surgical Pathology Clinics
Verified
Journal Article
Closed access
AMAmir Momeni-Boroujeni
Amir Momeni-Boroujeni
RMRajmohan Murali
Rajmohan Murali